Parameters

Test

Reference

P value

 

P

M

P

M

P

M

AUC(0-t) ((µg h/mL))

 AUC(0-∞) ((µg h/mL))

3.13 ± 1.03

4.70 ± 1.40

7.26 ± 3.72

28.50 ± 19.76

3.28 ± 1.08

5.02 ± 1.99

7.33 ± 4.04

26.40 ± 19.55

0.23

0.20

0.45

0.15

AUMC(0-t) ((µg h/mL))

17.58 ± 12.15

72.49 ± 68.89

19.98 ± 14.54

73.93 ± 72.51

0.20

0.46

Cmax (µg/mL)

0.41 ± 0.07

0.85 ± 0.28

0.42 ± 0.06

0.90 ± 0.28

0.26

0.05

Tmax (h)

0.90 ± 0.25

2.27 ± 0.49

1.04 ± 0.41

2.33 ± 0.38

0.08

0.31

t1/2 (h)

7.13 ± 2.00

57.78 ± 47.04

8.40 ± 6.17

48.74 ± 36.17

0.16

0.11

MRT (h)

10.94 ± 2.79

80.07 ± 65.43

12.54 ± 7.89

67.35 ± 50.59

0.16

0.11


P = Pioglitazone, M = Metformin, AUC = Area under curve, AUMC = Area under moment curve, Cmax = maximal plasma concentration, Tmax = time for the maximal plasma concentration, t1/2 = Elimination half life, MRT = Mean residence time
Table 3: Pharmacokinetic parameters (mean ± S.D. of n = 24) of pioglitazone and Metformin after 15/850 mg pioglitazone/metformin tablets based on its plasma concentrations.
Goto home»